Global Organ-on-Chip Market (Updated Version Available)

Report Overview
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Organ-on-Chip is a fledgling industry. Most companies come from university laboratories and are in the stage of financing. Very few companies are commercialized and sold on a large scale. Although most of the companies trying to enter the industry are start-ups, many large companies (such as Johnson & Johnson) are eager to try because of their wide range of applications, including pharmaceuticals, cosmetics, agriculture, food and so on. The United States, UK, the Netherlands and France have given priority to occupying most of the markets. Relatively speaking, the overall market in Asia is relatively blank. It is expected that South Korea, Japan and Taiwan will accelerate the pace of research. Product types are still mainly concentrated in the liver, kidney, heart, blood vessels and so on. The company will continue to expand the scope of research, such as bone, muscle, nerve, skin and other organs.

This research report gives detailed data about the major factors influencing the growth of the Organ-on-Chip market at the national and local level forecast of the market size, in terms of value, market share by region, and segment; regional market positions; segment and country opportunities for growth; Key company profiles, SWOT, product portfolio and growth strategies. It studies the market\'s essential sides such as top participants, expansion strategies, business models, and other market features to improve market insight.

The report forecast global Organ-on-Chip market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2026.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Organ-on-Chip market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.


First, this report covers the present status and the future prospects of the global Organ-on-Chip market for 2015-2026.

Market Segmentation
The Organ-on-Chip market is segmented on the basis of type, application, end-use industry, and region & country.
Key Companies
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory

At the same time, we classify Organ-on-Chip according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market by Order Type
Liver-on-a-chip
Kidney-on-a-chip
Intestine-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Other Organs
Market by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Other End Users

Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Organ-on-Chip market for the forecast period 2021 - 2026?
• What are the driving forces in the Organ-on-Chip market for the forecast period 2021 - 2026?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Organ-on-Chip industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?

For any other requirements, please feel free to contact us and we will provide you customized report.